Amarin Corporation plc - American Depositary Receipt

Amarin Corporation plc - American Depositary Receipt represents shares in Amarin Corporation plc, a pharmaceutical company focused on the commercialization and development of therapeutics for cardiovascular health in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. Amarin Corporation plc operates within the health technology sector, specifically pharmaceuticals, targeting cardiovascular diseases through innovative lipid management solutions. Founded in 1989 and headquartered in Dublin, Ireland, this American Depositary Receipt provides U.S. investors access to the company's ongoing efforts in therapeutic advancement and market commercialization for cardiovascular risk reduction.